Kestra Advisory Services’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57.1K Buy
33,191
+16,915
+104% +$29.1K ﹤0.01% 2757
2025
Q1
$54.2K Sell
16,276
-30,865
-65% -$103K ﹤0.01% 2640
2024
Q4
$349K Buy
47,141
+36,196
+331% +$268K ﹤0.01% 2116
2024
Q3
$103K Sell
10,945
-20,830
-66% -$196K ﹤0.01% 2452
2024
Q2
$101K Buy
31,775
+2,692
+9% +$8.56K ﹤0.01% 2513
2024
Q1
$431K Buy
+29,083
New +$431K ﹤0.01% 1760